SMI Reports: Sanofi will deliver a presentation at the inaugural Disruptive Technologies in Pharma conference taking place in London on 20th – 21st London 2020. Sanofi joins a programme filled with expert presentations from a […]
Sangamo Therapeutics, a genomic medicine company, announced today that the United Kingdom’s (UK) Medicines Healthcare Products Regulatory Agency (MHRA) has granted authorization of the first-in-human clinical trial to evaluate a Chimeric Antigen Receptor Regulatory T […]
Janssen Pharmaceutical has received approval from the European Commission (EC) to market Darzalex (daratumumab) in combination with lenalidomide and dexamethasone (DRd) for multiple myeloma. The drug is indicated for newly diagnosed patients ineligible for autologous […]
CNS Pharmaceuticals, a biotechnology company specializing in the development of novel treatments for brain tumors, completed an agreement with Houston Pharmaceuticals, Inc. (“HPI”) to obtain the rights to a worldwide, exclusive royalty-bearing, license for the […]
SMi Reports: University of Cambridge speaker to brief on Artificial Intelligence for AI in Drug Discovery 2020 taking place in London in March 2020. The upcoming inaugural AI in Drug Discovery conference is set to […]